Pharming Group N.V. (AMS:PHARM)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
1.109
-0.025 (-2.21%)
Nov 4, 2026, 5:35 PM CET

Pharming Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
24.182.85-11.84-10.5513.6716
Depreciation & Amortization
11.0610.3210.1910.139.339.17
Other Amortization
0.890.890.850.88--
Loss (Gain) From Sale of Assets
----21.28--
Asset Writedown & Restructuring Costs
--5.034.923.8610.44
Loss (Gain) From Sale of Investments
-2.35-2.35-4.990.93-11.06-0.11
Loss (Gain) on Equity Investments
-1.14-0.621.760.291.08-0.69
Stock-Based Compensation
12.8613.7711.259.256.399.06
Other Operating Activities
13.1319.46-3.975.09-0.44-1.05
Change in Accounts Receivable
-29.61-3.36-6.78-18.542.365.92
Change in Inventory
-0.97-1.29-0.5-14.43-15.02-6.15
Change in Accounts Payable
5.1914.13-2.7716.2311.99-5.19
Change in Other Net Operating Assets
2.120.9-0.02-0.220.270.47
Operating Cash Flow
35.3754.71-1.8-17.322.4637.84
Operating Cash Flow Growth
-33.68%----40.65%-54.75%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.87-0.75-0.79-1.44-1.38-10.74
Cash Acquisitions
--57.48----
Sale (Purchase) of Intangibles
--0.01-0.0121.25-0.6-5.98
Investment in Securities
-84.384.4832.41-149.27.3-4.59
Other Investing Activities
-0-0----
Investing Cash Flow
-85.1726.2531.62-129.395.32-21.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--104.54---
Long-Term Debt Repaid
--4.25-138.93-4.04-3.31-3.22
Lease Payments
-16.17-4.25-4.01-4.04-3.31-3.22
Net Debt Issued (Repaid)
-16.17-4.25-34.39-4.04-3.31-3.22
Issuance of Common Stock
10.9519.815.588.132.284.72
Other Financing Activities
-5.81-14.07-5.6-5.13-3.95-29.45
Financing Cash Flow
-11.031.5-34.41-1.04-4.98-27.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.227.91-2.212.13-7.38-1.83
Miscellaneous Cash Flow Adjustments
117.8-0----
Net Cash Flow
57.1990.36-6.8-145.615.42-13.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
34.553.96-2.59-18.7421.0827.1
Free Cash Flow Growth
-34.56%----22.21%-65.68%
Free Cash Flow Margin
8.92%14.35%-0.87%-7.64%10.25%13.63%
Free Cash Flow Per Share
0.040.07-0.00-0.030.030.04
Levered Free Cash Flow
42.4768.650.248.0616.23-17.14
Unlevered Free Cash Flow
46.1175.355.711.7819.58-13.33
Free Cash Flow After Leases
18.3349.71-6.59-22.7817.7723.89

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
5.816.25.65.133.954.45
Cash Income Tax Paid
7.794.615.580.661.24-
Change in Working Capital
-23.2710.39-10.07-16.96-0.39-4.96